Natus Medical Incorporated is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.

Company profile
Ticker
NTUS
Exchange
Website
CEO
Jonathan Kennedy
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Masimo • LivaNova • Outset Medical • Fonar • Cutera • Inmode • Star Equity ...
SEC CIK
Corporate docs
Subsidiaries
Natus Manufacturing Limited • Natus Medical Denmark ApS • Excel-Tech Corp. ...
IRS number
770154833
NTUS stock data
News
Natus Medical Q1 EPS $0.22 Misses $0.26 Estimate, Sales $119.80M Beat $115.70M Estimate
5 May 22
Earnings Scheduled For May 5, 2022
5 May 22
68 Biggest Movers From Yesterday
19 Apr 22
Mid-Afternoon Market Update: Crude Oil Rises Over 1%; Nektar Therapeutics Shares Slide
18 Apr 22
12 Health Care Stocks Moving In Monday's Intraday Session
18 Apr 22
Press releases
INVESTIGATION NOTICE: Halper Sadeh LLP Investigates USWS, GDST, NTUS, CMAX
23 Jun 22
Shareholder Alert - The M&A Class Action Firm is Investigating the Merger - BKEP, PSB, SREV, NTUS, SAIL
22 Jun 22
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates TREC, CVET, NTUS
7 Jun 22
NATUS MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Natus Medical Incorporated - NTUS
6 Jun 22
SHAREHOLDER UPDATE: Halper Sadeh LLP Investigates CMAX, TVTY, GTYH, NTUS
2 Jun 22
Calendar
6 May 22
2 Jul 22
31 Dec 22
Financial summary
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jun 22 | Daskal Ilan | Common Stock, $0.001 par value per share | Grant | Acquire A | No | No | 0 | 5,075 | 0 | 18,937 |
15 Jun 22 | Eric Guerin | Common Stock, $0.001 par value per share | Grant | Acquire A | No | No | 0 | 4,315 | 0 | 10,114 |
15 Jun 22 | Heine Lisa Wipperman | Common Stock, $0.001 par value per share | Grant | Acquire A | No | No | 0 | 5,075 | 0 | 26,287 |
15 Jun 22 | Levine Joshua | Common Stock, $0.001 par value per share | Grant | Acquire A | No | No | 0 | 5,075 | 0 | 37,387 |
15 Jun 22 | Bryant M Moore | Common Stock, $0.001 par value per share | Grant | Acquire A | No | No | 0 | 4,315 | 0 | 10,114 |
Institutional ownership, Q1 2022
92.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 166 |
Opened positions | 13 |
Closed positions | 17 |
Increased positions | 65 |
Reduced positions | 59 |
13F shares | Current |
---|---|
Total value | 838.95M |
Total shares | 31.96M |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 6.51M | $170.99M |
Vanguard | 3.06M | $80.39M |
Victory Capital Management | 2.64M | $69.68M |
Allspring Global Investments | 2.1M | $55.11M |
Dimensional Fund Advisors | 1.4M | $36.76M |
STT State Street | 1.35M | $35.36M |
JHG Janus Henderson | 1.16M | $30.51M |
AMP Ameriprise Financial | 1.12M | $29.39M |
Nuveen Asset Management | 811.22K | $20.47M |
JPM JPMorgan Chase & Co. | 635.94K | $16.71M |
Financial report summary
?Risks
- The Company is subject to business uncertainties, litigation risk and contractual restrictions while the Merger is pending, which may adversely affect our business, financial condition and results of operations.
- Failure to consummate the proposed Merger within the expected timeframe or at all could negatively impact the price of our common stock, as well as our business, financial condition and results of operations.
- The Company's ability to complete the Merger is subject to certain closing conditions and the receipt of consents and approvals from government entities which may impose conditions that could adversely affect the Company or cause the Merger to be abandoned.
- The ongoing conflict between Russia and Ukraine has impacted our results of operations and could create or exacerbate certain risks we face to our business, financial condition and results of operations.
Management Discussion
- Our business and operating results are driven in part by worldwide economic conditions. Our revenue is significantly dependent on both capital spending by hospitals in the United States and healthcare spending by ministries of health outside the United States. While we have no direct exposure to Russia and Ukraine, we are monitoring any broader economic impact from the current crisis, especially on commodities.
- We experienced an increase in demand in the United States and Europe, during the first quarter compared to the same period in the prior year. Our consolidated revenue for the first quarter ended March 31, 2022 was $119.8 million compared to $114.9 million in the first quarter of the previous year, an increase of $4.9 million.
- Our net income was $1.9 million or $0.06 per diluted share in the three months ended March 31, 2022, compared with net income of $2.4 million or $0.07 per diluted share in the same period in 2021. The decrease in net
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
abandoned, abandonment, absence, accelerate, achieved, achievement, acquisition, acute, addressed, agreed, ALGO, alternative, anniversary, antitrust, appraisal, approval, April, attained, attract, Aurical, automatically, body, broader, Camino, cancelled, capture, carpal, carryback, case, CEO, Christopher, Chung, Codification, compensatory, complement, comprised, concurrently, conflict, consummate, consummated, consummation, contemplated, convened, converted, correct, cumulative, Cut, Dantec, death, deemed, degree, Delaware, diagnose, diagnosing, Digital, disability, disease, dystonia, economy, education, EEG, elapsed, Elite, Embla, EMG, enacted, enactment, encourage, energy, enjoining, entitled, escalation, exacerbate, exacerbated, exercise, experimental, expiration, extinguished, face, facing, failed, fashion, favorable, fee, fifteen, forfeit, forfeited, forfeiture, geopolitical, GILTI, good, hardware, hemorrhagic, imposition, impression, inability, inclusion, incurrence, inflation, innovative, intensified, invasion, IRC, issuable, January, large, legislation, life, litigation, low, macroeconomic, Madsen, magnitude, mandatory, maximum, merger, Mergerco, modified, motivate, movement, multiplied, muscle, myasthenia, nature, NCS, neoBLUE, nerve, neural, Nicolet, NICU, notwithstanding, null, Olympic, option, Otoscan, par, Parent, Parkinson, pediatric, pendency, pending, perfected, peripheral, personnel, physiological, pinched, premature, prematurity, President, Prince, procuring, professional, prohibiting, prolonged, prorated, PSG, pursue, Quantum, raw, receipt, regular, relevant, repealed, restraining, retain, retaliatory, RetCam, retention, retinopathy, Russia, satisfied, stabilize, stemming, streaming, stroke, Subpart, subsidiary, Sullivan, Superior, surviving, syndrome, target, temperature, testing, thereof, thereon, thereto, treasury, treat, treated, treating, trend, Trex, true, trusted, tunnel, Ukraine, UltraPro, unconditional, understanding, undertaken, variety, vertigo, vest, vested, vesting, video, void, waiting, waived, Xltek
Removed:
account, adapting, ahead, AOCI, arrange, assessed, assured, audiological, borrow, category, central, collaboration, collected, context, COVID, cranial, declared, delayed, derivative, diagnostic, diverse, Emergency, enabled, enhance, entry, environment, established, evaluating, exiting, extensive, external, field, firm, forced, forecasted, geographically, growth, handle, hedge, incident, instrumentation, Intensive, interruption, intraoperative, involving, Jonathan, Kennedy, laboratory, mitigation, model, mutually, Neuro, neurological, neurosurgery, online, onset, Organization, otoneurologic, partner, payroll, Pediatrix, Peloton, persist, policy, precaution, preceding, presence, prioritize, profitable, program, reclassified, recognition, recommended, record, recovery, recur, reliably, relief, repaid, repurchase, schedule, scope, seek, sensitive, serve, shift, size, small, sophisticated, stated, strategy, strong, Subsidy, surgical, swap, typically, unknown, unrealized, valuation, varying, Wage, worked
Financial reports
Current reports
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 22
8-K
Natus Medical Announces First Quarter 2022 Financial Results
4 May 22
8-K
Natus Medical Incorporated to be acquired by ArchiMed Group for $33.50 per share in cash
18 Apr 22
8-K
Natus Medical Announces Fourth Quarter 2021 Financial Results
24 Feb 22
8-K
Natus Announces Preliminary 2021 Fourth Quarter and Full Year Revenue
10 Jan 22
8-K
Natus Medical Announces Executive Transition
17 Dec 21
8-K
Natus Medical Announces Third Quarter 2021 Financial Results
4 Nov 21
8-K
Bryant M. Moore, Ph.D. and Eric J. Guerin Appointed to Natus Board of Directors
18 Aug 21
8-K
Natus Medical Announces Second Quarter 2021 Financial Results
5 Aug 21
8-K
Natus Chairperson Dr. Barbara Paul Retires; Board Elects Current Board Member Joshua Levine as Chairperson
28 Jun 21
Registration and prospectus
S-8
Registration of securities for employees
16 Jul 21
S-8
Registration of securities for employees
22 Jan 19
RW
Registration withdrawal request
27 Nov 11
S-8
Registration of securities for employees
2 Jun 11
424B5
Prospectus supplement for primary offering
22 May 08
424B5
Prospectus supplement for primary offering
13 May 08
424B5
Prospectus supplement for primary offering
12 May 08
S-3/A
Shelf registration (amended)
12 May 08
S-3
Shelf registration
28 Apr 08
Proxies
DEFM14A
Proxy related to merger
2 Jun 22
PREM14A
Preliminary proxy related to merger
23 May 22
DEFA14A
Additional proxy soliciting materials
28 Apr 22
DEFA14A
Additional proxy soliciting materials
18 Apr 22
DEFA14A
Additional proxy soliciting materials
18 Apr 22
DEFA14A
Additional proxy soliciting materials
28 Apr 21
DEFA14A
Additional proxy soliciting materials
8 May 20
DEF 14A
Definitive proxy
8 May 20
Other
SD
Conflict minerals disclosure
25 May 22
SD
Conflict minerals disclosure
27 May 21
SD
Conflict minerals disclosure
29 May 20
SD
Conflict minerals disclosure
31 May 19
UPLOAD
Letter from SEC
29 Jul 18
CORRESP
Correspondence with SEC
19 Jul 18
UPLOAD
Letter from SEC
11 Jul 18
UPLOAD
Letter from SEC
28 May 18
UPLOAD
Letter from SEC
22 May 18
UPLOAD
Letter from SEC
16 May 18
Ownership
4
NATUS MEDICAL / ALICE D. SCHROEDER ownership change
17 Jun 22
4
NATUS MEDICAL / BRYANT M MOORE ownership change
17 Jun 22
4
NATUS MEDICAL / JOSHUA LEVINE ownership change
17 Jun 22
4
NATUS MEDICAL / Lisa Wipperman Heine ownership change
17 Jun 22
4
NATUS MEDICAL / Eric Guerin ownership change
17 Jun 22
4
NATUS MEDICAL / Ilan Daskal ownership change
17 Jun 22
SC 13G/A
NATUS MEDICAL / VANGUARD ownership change
9 Feb 22
SC 13G/A
NATUS MEDICAL / VICTORY CAPITAL MANAGEMENT ownership change
2 Feb 22
SC 13G/A
NATUS MEDICAL / BlackRock ownership change
27 Jan 22
SC 13G/A
NATUS MEDICAL / BlackRock ownership change
25 Jan 22
Patents
Utility
Real-time removal of IR LED reflections from an image
23 Nov 21
A system for the real-time removal of reflections from an image including a head wearable device, a first illuminator, a second illuminator, at least one camera and a reflection removal processor.
Utility
Wideband Acoustic Immittance Measurement Apparatus
21 Oct 21
A wideband acoustic immittance measurement apparatus including an ear probe having an acoustic output port for emitting sound into an ear canal and an acoustic input port for receiving sound from the ear canal, a loudspeaker that is acoustically connected with the acoustic output port, a microphone acoustically connected with the acoustic input port for generating an audio signal as a function of sound received at the acoustic input port, and a processor for controlling the loudspeaker to emit sound spanning a frequency range and receiving the audio signal of the microphone, determining a complex acoustic admittance Y(f)=G(f)+jB(f) as a function of frequency f based on the emitted sound and the received audio signal, and identifying at least one middle ear resonance based on both the real and imaginary part of the determined acoustic admittance as a function of frequency f.
Utility
Vestibular Testing Apparatus
7 Oct 21
A system for detecting and recording head orientations of a person includes: a first sensor device capable of providing sensor data regarding a head orientation of a person in a three-dimensional space; a data acquisition system configured for storing and outputting the sensor data from the first sensor device; and a processor configured for processing the sensor data from the data acquisition system, outputting a first signal representing the head orientation, and generating an image for presentation by a graphical display; wherein the image comprises: a first reference indicator; an orientation indicator, wherein a position of the orientation indicator in the image is determined based on the first signal from the processor, and a feedback indicator when a first condition is met.
Utility
User Interface for an Audiological Test System
2 Sep 21
A audiological test system is provided for audiological testing of a patient situated at a test location, comprising a first display screen for monitoring of the audiological test system and that is positioned outside a viewing field of the patient when the patient is situated at the test location, a second display screen positioned within the viewing field of the patient when the patient is situated at the test location, a first switch located at the first display screen and adapted for control of the second display screen in such a way that predetermined information relating to operation of the audiological test system is not displayed on the second display screen upon activation of the first switch, and a second switch located at the second display screen and adapted for control of the second display screen in such a way that the predetermined information relating to operation of the audiological test system is displayed on the second display screen upon activation of the second switch.
Utility
Wideband acoustic immittance measurement apparatus
3 Aug 21
A new wideband acoustic immittance measurement apparatus is provided for determination of wideband acoustic immittance in the ear of the human, the apparatus comprising an ear probe for insertion in an ear canal of the human and having an acoustic output port for emission of sound into the ear canal of the human, and an acoustic input port for reception of sound from the ear canal of the human, and a loudspeaker that is arranged for acoustical connection with the acoustic output port of the ear probe for emission of the sound, and a microphone that is arranged for acoustical connection with the acoustic input port of the ear probe for generation of an audio signal as a function of sound received at the acoustic input port, and a processor that is adapted for controlling the loudspeaker to emit sound spanning a frequency range, and receiving the audio signal of the microphone, determining a complex acoustic admittance Y(f)=G(f)+jB(f) as a function of frequency f based on the emitted sound and the received audio signal, and identifying at least one middle ear resonance based on both the real and imaginary part of the determined acoustic admittance as a function of frequency f.
Transcripts
2021 Q4
Earnings call transcript
25 Feb 22
2021 Q3
Earnings call transcript
5 Nov 21
2021 Q2
Earnings call transcript
8 Aug 21
2021 Q1
Earnings call transcript
9 May 21
2020 Q4
Earnings call transcript
28 Feb 21
2020 Q3
Earnings call transcript
31 Oct 20
2020 Q2
Earnings call transcript
2 Aug 20
2020 Q1
Earnings call transcript
2 May 20
2019 Q4
Earnings call transcript
6 Feb 20
2019 Q3
Earnings call transcript
26 Oct 19
Reddit threads
Daily Discussion Thread - May 5th, 2022
5 May 22
Daily Discussion Thread - May 4th, 2022
4 May 22
Daily Discussion Thread - February 24th, 2022
24 Feb 22
Daily Discussion Thread - February 23rd, 2022
23 Feb 22
Daily Discussion Thread - February 22nd, 2022
22 Feb 22
Daily Discussion Thread - February 21st, 2022
21 Feb 22
Daily Discussion Thread - November 4th, 2021
4 Nov 21
Daily Discussion Thread - November 3rd, 2021
3 Nov 21
Daily Discussion Thread - August 5th, 2021
5 Aug 21
Daily Discussion Thread - August 4th, 2021
4 Aug 21